Evidence map›Paper›PMID 31518861›Full record

ArticleJournal of pharmaceutical and biomedical analysis2020

Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data.

Tyler Cook, Yinfa Ma, Sanjeewa Gamagedara

Abstract readEvaluation Study
In one paragraph

Article in Journal of pharmaceutical and biomedical analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Metabolomics Data Treatment: Basic Directions of the Full Process.Advances in experimental medicine and biology · 2021
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tyler CookDepartment of Mathematics & Statistics, University of Central Oklahoma, 100 North University Drive, Edmond, OK 73034, United States.
Yinfa MaCollege of Natural Sciences and Mathematics, California State University - Sacramento, 6000 J Street, Sacramento, CA 95819, United States.
Sanjeewa GamagedaraDepartment of Chemistry, University of Central Oklahoma, 100 North University Drive, Edmond, OK 73034, United States; Center for Interdisciplinary Biomedical Education and Research, University of Central Oklahoma, 100 North University Drive, Edmond, OK 73034, United States. Electronic address: sgamagedara@uco.edu.

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Mark L Lang · 2012 to 2026
$60.2M
NIGMS NIH HHS P20 GM103447
6 · The paper itself

Abstract

Human urine recently became a popular medium for metabolomics biomarker discovery because its collection is non-invasive. Sometimes renal dilution of urine can be problematic in this type of urinary biomarker analysis. Currently, various normalization techniques such as creatinine ratio, osmolality, specific gravity, dry mass, urine volume, and area under the curve are used to account for the renal dilution. However, these normalization techniques have their own drawbacks. In this project, mass spectrometry-based urinary metabolomic data obtained from prostate cancer (n = 56), bladder cancer (n = 57) and control (n = 69) groups were analyzed using statistical normalization techniques. The normalization techniques investigated in this study are Creatinine Ratio, Log Value, Linear Baseline, Cyclic Loess, Quantile, Probabilistic Quotient, Auto Scaling, Pareto Scaling, and Variance Stabilizing Normalization. The appropriate summary statistics for comparison of normalization techniques were created using variances, coefficients of variation, and boxplots. For each normalization technique, a principal component analysis was performed to identify clusters based on cancer type. In addition, hypothesis tests were conducted to determine if the normalized biomarkers could be used to differentiate between the cancer types. The results indicate that the determination of statistical significance can be dependent upon which normalization method is utilized. Therefore, careful consideration should go into choosing an appropriate normalization technique as no method had universally superior performance.

Indexed as

Biomarkers, TumorCreatinineData Interpretation, StatisticalDatasets as TopicHumansMaleMetabolomicsPrincipal Component AnalysisProstatic NeoplasmsUrinalysisUrinary Bladder NeoplasmsBiomarkers, TumorCreatinineBiomarkersLC/MS/MSMetabolomicsNormalizationUrine

Identifiers

PMID31518861
PMCPMC6823157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.